Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Core Laboratories (CLB) EBITDA Margin (2022 - 2025)

Core Laboratories (CLB) has 4 years of EBITDA Margin data on record, last reported at 18.18% in Q3 2025.

  • For Q3 2025, EBITDA Margin rose 80.0% year-over-year to 18.18%; the TTM value through Sep 2025 reached 3.87%, down 1021.0%, while the annual FY2024 figure was 4.58%, 914.0% down from the prior year.
  • EBITDA Margin reached 18.18% in Q3 2025 per CLB's latest filing, up from 14.48% in the prior quarter.
  • Across five years, EBITDA Margin topped out at 18.18% in Q3 2025 and bottomed at 24.21% in Q4 2024.
  • Average EBITDA Margin over 4 years is 10.91%, with a median of 14.74% recorded in 2023.
  • The widest YoY moves for EBITDA Margin: up 264bps in 2024, down -3851bps in 2024.
  • A 4-year view of EBITDA Margin shows it stood at 15.3% in 2022, then decreased by -7bps to 14.29% in 2023, then crashed by -269bps to 24.21% in 2024, then soared by 175bps to 18.18% in 2025.
  • Per Business Quant database, its latest 3 readings for EBITDA Margin were 18.18% in Q3 2025, 14.48% in Q2 2025, and 6.48% in Q1 2025.